The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Johnson, P. J., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M., Reeves, H. L., O'Beirne, J., Fox, R., Skowronska, A., Palmer, D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.9151 · Cited by 2,783
Self-citationInformation theory as an extension of the maximum likelihood principle
Akaike, H. (1973) · Medical Entomology and Zoology · Cited by 2,357
Dichotomizing continuous predictors in multiple regression: a bad idea
Royston, P., Altman, D. G., & Sauerbrei, W. (2006) · Statistics in Medicine · doi:10.1002/sim.2331 · Cited by 2,312
SINGAL, A., VOLK, M. L., WALJEE, A., SALGIA, R., HIGGINS, P., ROGERS, M. A. M., & MARRERO, J. A. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04014.x · Cited by 819
Marrero, J. A., Feng, Z., Wang, Y., Nguyen, M. H., Befeler, A. S., Roberts, L. R., Reddy, K. R., Harnois, D., Llovet, J. M., Normolle, D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.005 · Cited by 745
Bolondi, L., Sofia, S., Siringo, S., Gaiani, S., Casali, A., Zironi, G., Piscaglia, F., Gramantieri, L., Zanetti, M., & Sherman, M. (2001) · Gut · doi:10.1136/gut.48.2.251 · Cited by 643
Kudo, M., Matsui, O., Izumi, N., Iijima, H., Kadoya, M., Imai, Y., Okusaka, T., Miyayama, S., Tsuchiya, K., Ueshima, K., et al. (2014) · Liver Cancer · doi:10.1159/000343875 · Cited by 615
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
Dyson, J., Jaques, B., Chattopadyhay, D., Lochan, R., Graham, J., Das, D., Aslam, T., Patanwala, I., Gaggar, S., Cole, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.011 · Cited by 603 · cited 6×
“We assessed the performance of BALAD-2 in patients with different stages of HCC. RESULTS: In all cohorts, the area under the receiver operating characteristic curve (AUROC), quantifying the ability of GALAD to discriminate patients with HCC from patients with chronic liver disease, was greater than 0.90—similar to the…”
BackgroundInfluentialComparing the Predictive Powers of Survival Models Using Harrell's C or Somers’ D
Newson, R. B. (2010) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1001000303 · Cited by 424
Metabolic syndrome and hepatocellular carcinoma: Two growing epidemics with a potential link
Siegel, A. B., & Zhu, A. X. (2009) · Cancer · doi:10.1002/cncr.24687 · Cited by 399
Johnson, P. J., Pirrie, S. J., Cox, T. F., Berhane, S., Teng, M., Palmer, D., Morse, J., Hull, D., Patman, G., Kagebayashi, C., et al. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0870 · Cited by 350
Self-citationReport of the 18th follow‐up survey of primary liver cancer in Japan
Ikai, I., Kudo, M., Arii, S., Omata, M., Kojiro, M., Sakamoto, M., Takayasu, K., Hayashi, N., Makuuchi, M., Matsuyama, Y., et al. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00731.x · Cited by 158
Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers
Toyoda, H., Kumada, T., Osaki, Y., Oka, H., Urano, F., Kudo, M., & Matsunaga, T. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.021 · Cited by 132
Self-citationCaviglia, G. P., Abate, M. L., Petrini, E., Gaia, S., Rizzetto, M., & Smedile, A. (2015) · Hepatology Research · doi:10.1111/hepr.12544 · Cited by 70
Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model
Fox, R., Berhane, S., Teng, M. J., Cox, T. F., Tada, T., Toyoda, H., Kumada, T., Kagebayashi, C., Satomura, S., & Johnson, P. J. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.130 · Cited by 65
Self-citationTreatment of continuous data as categoric variables in
DELPRIORE, G., Zandieh, P., & LEE, M. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(96)00504-2 · Cited by 39
Applicability of BALAD score in prognostication of hepatitis B ‐related hepatocellular carcinoma
Chan, S. L., Mo, F. K. F., Johnson, P. J., Li, L., Tang, N. L. S., Loong, H. H.-F., Chan, A. W. H., Koh, J., Chan, A. T. �., & Yeo, W. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13005 · Cited by 17
Self-citationChapter 2: Diagnosis and surveillance
(2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00655.x · Cited by 10
Cited by
Forner, A., Reig, M., & Bruix, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30010-2 · Cited by 5,531
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Singal, A. G., Llovet, J. M., Yarchoan, M., Mehta, N., Heimbach, J. K., Dawson, L. A., Jou, J. H., Kulik, L. M., Agopian, V. G., Marrero, J. A., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000466 · Cited by 2,052
“[78] GALAD was subsequently evaluated in a large Phase III biomarker study, the Hepatocellular carcinoma Early Detection Strategy (HEDS) study, in which it was found to have a sensitivity and specificity of 65% and 82% for HCC, respectively [79] There has also been interest in use of liquid biopsy…”
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Self-citationEpidemiology and surveillance for hepatocellular carcinoma: New trends
Singal, A. G., Lampertico, P., & Nahon, P. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.025 · Cited by 1,102
Metadata
- Authors
- Berhane, S., Toyoda, H., Tada, T., Kumada, T., Kagebayashi, C., Satomura, S., Schweitzer, N., Vogel, A., Manns, M. P., Benckert, J., Berg, T., Ebker, M., Best, J., Dechêne, A., Gerken, G., Schlaak, J. F., Weinmann, A., Wörns, M. A., Galle, P., Yeo, W., Mo, F., Chan, S. L., Reeves, H., Cox, T., & Johnson, P.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 14
- Issue
- 6
- Pages
- 875-886.e6
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2238063610
- Cited by
- 323
- References
- 21
- FWCI
- 13.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.